Lowy calls for expanding NCI’s clinical impact, including: (1) the number of drug candidates, (2) the clinical trials system, and (3) access to cancer care

Hoping to hit a $200M target, NCI and FNIH develop a plan for advancing cancer vaccines
NCI Director Letai: “How aggressive can we be?”

A public-private effort, spearheaded by NCI Director Anthony Letai, and led by the Foundation for the National Institutes of Health, is working to speed up the development of therapeutic cancer vaccines.

March 20, 2026

Vol.52 No.11

By Claire Marie Porter

NCI

Letai: “From this point forward, it really is much more like business as usual at the NCI.”

NCI Director Anthony Letai appeared before the National Cancer Advisory Board Committee March 17 to maneuver through thorny topics while reiterating his message of reassurance: Stability. Stability. Stability.

House bill proposes to exempt health care workers from H-1B visa $100,000 fee

The H–1Bs for Physicians and the Healthcare Workforce Act—introduced by Rep. Sanford D. Bishop, Jr. (D-GA) and Rep. Mike Lawler (R-NY)—would exempt physicians and health care workers from a recently imposed $100,000 fee now required to obtain an H-1B visa, which allows foreign nationals in “specialty occupations” to live and work in the U.S. The fee was previously $5,000 to $10,000.

Kim Rathmell named OSUCCC director, Pollock becomes director emeritus in planned leadership transition

W. Kimryn Rathmell, CEO of the James Cancer Hospital and Solove Research Institute, has also been named director of The Ohio State University Comprehensive Cancer Center in place of former Director Raphael E. Pollock, who has stepped down from the position he had held since November 2017 to become OSUCCC director emeritus.

March 06, 2026

Vol.52 No.09

Podcast The Directors

The Directors: Yolanda Sanchez and Kelvin Lee talk about making cancer centers more resilient
“Diverse ecosystems are more robust than non-diverse ecosystems. That is a biological fact.”

“We’ve always argued that money comes and goes, but if you lose a generation of scientists—you can’t buy them back,” said Kelvin Lee, director of the Indiana University Simon Comprehensive Cancer Center.

February 27, 2026

Vol.52 No.08

By Claire Marie Porter and Paul Goldberg

In Brief

Neal Meropol named PI of ASCO’s TAPUR study

Neal J. Meropol was named principal investigator of the American Society of Clinical Oncology’s Targeted Agent and Profiling Utilization Registry study.

February 27, 2026

Vol.52 No.08

Lowy calls for expanding NCI’s clinical impact, including: (1) the number of drug candidates, (2) the clinical trials system, and (3) access to cancer care

YOU MAY BE INTERESTED IN

Hoping to hit a $200M target, NCI and FNIH develop a plan for advancing cancer vaccines
NCI Director Letai: “How aggressive can we be?”

Letai: “From this point forward, it really is much more like business as usual at the NCI.”

House bill proposes to exempt health care workers from H-1B visa $100,000 fee

Kim Rathmell named OSUCCC director, Pollock becomes director emeritus in planned leadership transition

The Directors: Yolanda Sanchez and Kelvin Lee talk about making cancer centers more resilient
“Diverse ecosystems are more robust than non-diverse ecosystems. That is a biological fact.”

Neal Meropol named PI of ASCO’s TAPUR study

Renew today!

Subscriber content

Never miss an issue!

Login

Lowy calls for expanding NCI’s clinical impact, including: (1) the number of drug candidates, (2) the clinical trials system, and (3) access to cancer care

YOU MAY BE INTERESTED IN

Hoping to hit a $200M target, NCI and FNIH develop a plan for advancing cancer vaccinesNCI Director Letai: “How aggressive can we be?”

Letai: “From this point forward, it really is much more like business as usual at the NCI.”

House bill proposes to exempt health care workers from H-1B visa $100,000 fee

Kim Rathmell named OSUCCC director, Pollock becomes director emeritus in planned leadership transition

The Directors: Yolanda Sanchez and Kelvin Lee talk about making cancer centers more resilient“Diverse ecosystems are more robust than non-diverse ecosystems. That is a biological fact.”

Neal Meropol named PI of ASCO’s TAPUR study

Never miss an issue!

Login

Hoping to hit a $200M target, NCI and FNIH develop a plan for advancing cancer vaccines
NCI Director Letai: “How aggressive can we be?”

The Directors: Yolanda Sanchez and Kelvin Lee talk about making cancer centers more resilient
“Diverse ecosystems are more robust than non-diverse ecosystems. That is a biological fact.”